GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
F

Fusion Antibodies FAB.L · GBp

Health Care · LSE · 🇬🇧 United Kingdom

Compare

5.00p

-4.76%

Close of 9 Nov 2026, in pence

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Fusion Antibodies — daily FAB

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Fusion Antibodies on TradingView ↗
Market value
£6.3m
Last close × shares
Volume
595.7k
Shares, 9 Nov 2026

About Fusion Antibodies

Its shares trade on LSE under the ticker FAB.L. It has been listed since 18 December 2017. In the fiscal year to 31 March 2026, it reported revenue of £2.1m and a net loss of £1.1m. At that date it held total assets of £2.7m and shareholders' equity of £1.6m.

Fusion Antibodies Plc engages in the provision of antibody engineering services for all stages of therapeutic and diagnostic antibody development. The company is headquartered in Belfast, Northern Ireland. The company went IPO on 2017-12-18. The firm develops and commercializes antibody-based therapeutics for cancer. The firm develops a range of antibody engineering services based around monoclonal antibodies. The company focuses in the expression and purification of recombinant proteins and chimeric antibodies for the research, diagnostic and therapeutic markets. Its technology generates target specific antibodies from protein antigens. The firm's therapeutic and diagnostic research and development are offered as a service to pharmaceutical, biopharmaceutical and academic researchers.

Figures and description from our data supplier, not checked against the company's own report.

More about Fusion Antibodies →

Latest on Fusion Antibodies

Our reporting

We have not reported on Fusion Antibodies yet.

Next results

7 Dec 2026

Due on 7 Dec 2026.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Fusion Antibodies's ticker?

Fusion Antibodies trades as FAB.L on LSE, under ISIN GB00BDQZGK16.

What was Fusion Antibodies's last closing price?

5.00p on 9 Nov 2026. The figure is in GBp and is never converted.

When does Fusion Antibodies next report results?

Results are expected on 7 Dec 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.